this site is not intended for consumer use.

  • ​Delivers Free Curcumin

  • Developed in Collaboration with UCLA Neuroscientists
  • Multiple Clinical Trials
  • Regulatory Status: Self-GRAS; Published Safety 
  • Patented Protected (US 9192644, EP 1993365; Additional Patents Pending)
  • ​At least 67-285 Times More Bioavailable than Standard 95% Curcumin Depending upon Cmax, AUC, and AUC Normalized Calculations

These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Verdure Sciences, Longvida (US Patent 9192644, EP Patent 1993365; additional patents pending), Bacognize, Calzbone, Pomella (US Patents 7368640, 7897791, and 7919636; international patents pending), Tinofend, Factor21, and WokVel are registered trademarks of Verdure Sciences, Inc. Cinnagest, Rejuna, Thymocid, Gingerize, VBATS, VerdeMedica, SLP, and SLCP are trademarks of Verdure Sciences, Inc. All Rights Reserved. © 2016 Verdure Sciences.

Please note that the physiological activity of the ingredient(s) described herein is supported by the referenced clinical trial report(s). Marketers of finished products containing the ingredient(s) described herein are responsible for determining whether claims made for such products are lawful and in compliance with the laws of the country in which they will market the products.​

Dr. Robert DiSilvestro, The Ohio State University

Powered by patented (US Patent 9192644, EP Patent 1993365; additional patents pending) SLCP™ Technology, Longvida® Optimized Curcumin is a breakthrough formula of the natural antioxidant curcumin, from the turmeric root. It is optimized to deliver free curcumin into target tissues through the critical bioavailability requirements of permeability, solubility, and stability. Developed in collaboration with elite neuroscientists at UCLA, Longvida® carries a strong safety profile and is self-GRAS.

Dietary supplements like Longvida® are not intended to diagnose, treat,

cure, or prevent any disease. Please keep in mind that statements may

not be applicable in all countries. Claims on this site are specific to

Longvida, and make no reference to finished products. Consumers are

recommended to check with local legal counsel and/or healthcare

professional(s) before making any purchases of products and/or services

from our finished product partners.

Reduced inflammatory & muscle damage biomarkers after supplementation with bioavailable Curcumin 

The purpose of this study was to determine the effects of oral

supplementation of Longvida® 400 mg/days on muscle & ADL soreness, creatine kinase, and inflammatory cytokines following EMID. Subjects were randomly assigned to either curcumin or placebo (rice flour) and supplemented 2 days before to 4 days after EMID. Blood samples were collected prior to, and 1, 2, 3, and 4 days after EIMD to measure CK and inflammatory cytokines. Curcumin supplementation resulted in significantly smaller increases in CK (− 48%), TNF-α (− 25%), and IL-8 (− 21%) following EIMD compared to placebo. Continue Reading

Quick Facts

Dr. Robert DiSilvestro from The Ohio State University discusses Longvida® Optimized Curcumin.

​latest research & news


Mounting evidence suggests that curcumin, an ingredient in the Indian spice turmeric, has vascular protective effects in aging animals and humans. We tested the hypothesis that curcumin improves vascular endothelial function, as assessed by endothelium-dependent dilation (EDD), in middle-aged and older (MA/O) adults (45-74 yrs) by...

Continue Reading

product highlights

Longvida® Optimized Curcumin

Awarded 2015 'University Research of the Year' by NutraIngredients

Read More

Verdure Sciences, Inc © 2016 ALL RIGHTS RESERVED.